Showing results (51-60 of 121) with videos related to
Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|September 23, 2019
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trialsMichael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies GroupNaureen Starling, Sheela Rao, David Cunningham, et al.BMC Cancer|January 22, 2015
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experienceKhurum Khan, Clare Peckitt, Francesco Sclafani, et al.Current Oncology (Toronto, Ont.)|September 26, 2025
Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary CentreJulia Freckelton, Justin Mencel, Iris Levink, et al.British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2015
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010Elisa Fontana, Elizabeth C Smyth, David Cunningham, et al.Clinical Colorectal Cancer|November 9, 2018
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center ExperienceKhurum Khan, Jayant K Rane, David Cunningham, et al.Nature Ecology & Evolution|May 21, 2021
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancerAndrew Woolston, Louise J Barber, Beatrice Griffiths, et al.Pageof 13